Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 10.31M | $1.26B | 15.94% | +528.5K | 2026-06-30 |
| Farallon Capital Management, L.L.C. | 6.35M | $778.0M | 9.82% | -- | 2026-06-30 |
| Rtw Investments, LP | 5.06M | $620.0M | 7.83% | +2.1K | 2026-06-30 |
| Vanguard Portfolio Management LLC | 3.63M | $444.0M | 5.61% | -- | 2026-06-30 |
| Wellington Management Group LLP | 3.42M | $418.0M | 5.28% | -182.9K | 2026-06-30 |
| UBS Group AG | 3.40M | $416.0M | 5.26% | -1.78M | 2026-06-30 |
| State Street Corp | 3.32M | $407.0M | 5.14% | +204.8K | 2026-06-30 |
| Vanguard Capital Management LLC | 2.85M | $349.0M | 4.41% | -- | 2026-06-30 |
| Johnson & Johnson | 2.45M | $300.0M | 3.79% | -- | 2026-06-30 |
| Invesco Ltd. | 2.34M | $286.0M | 3.62% | +176.0K | 2026-06-30 |
